(Q41570418)

3 October 2017

0 references

In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy (English)

1 reference

3 October 2017

Clostridium difficile

0 references

author name string

Robert J Carman

1

1 reference

3 October 2017

James H Boone

2

1 reference

3 October 2017

Harish Grover

3

1 reference

3 October 2017

Kimberly N Wickham

4

1 reference

3 October 2017

Li Chen

5

1 reference

3 October 2017

language of work or name

English

0 references

publication date

20 August 2012

1 reference

Antimicrobial Agents and Chemotherapy

3 October 2017

1 reference

3 October 2017

56

1 reference

3 October 2017

11

1 reference

3 October 2017

6019-6020

1 reference

Divergent rifamycin susceptibilities of Clostridium difficile strains in Canada and Italy and predictive accuracy of rifampin Etest for rifamycin resistance

3 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486587

High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486587

Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486587

Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486587

PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486587

Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486587

In vivo selection of moxifloxacin-resistant Clostridium difficile

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486587

Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486587

A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22908175

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00974-12

1 reference

3 October 2017

1 reference

3 October 2017

PubMed publication ID

22908175

1 reference